How to treat spasmodic cough? There are 4 ways

Spasmodic cough is a common disease in daily life. It is often manifested as severe coughing fits that often affect breathing. In severe cases, dry retching may occur, which seriously affects people's normal work and life. So how should you treat a spasmodic cough? In fact, there are four methods. The first is to control the source of infection.

1. Control the source of infection . During the epidemic season, all confirmed patients should be immediately isolated until 40 days after the onset of the disease, or until 30 days after the spasmodic cough. Contacts should be closely observed for at least 3 weeks, and any prodromal symptoms should be treated with antibiotics as soon as possible.

2. Cut off the transmission route. Since Bordetella pertussis has weak resistance to the outside world, no disinfection is required. However, the room should be ventilated, clothes should be exposed to the sun, and sputum and oral and nasal secretions should be disinfected.

3. Improve the immunity of the population. The pertussis vaccines currently used for vaccination include whole-cell vaccines and acellular vaccines. Whole-cell vaccines are conventional vaccines, namely pertussis, diphtheria, and tetanus (DTP) preparations, and each 0.5 ml contains 4 pertussis protection units. Basic immunization is given to infants aged 3 to 6 months with 0.5, 1.0, and 1.0 ml subcutaneously for a total of 3 times, with an interval of 4 weeks between each time. During the epidemic period, infants aged 1 month can receive the vaccine, and a booster injection of intramuscular injection can be given at 1 to 2 years old. Some people also recommend that normal infants and children should receive the first dose of DTP vaccine at 2 months of age, the second dose at 4 months of age, the third dose at 6 months of age, the fourth dose at 15 months of age, and the fifth dose at 4 to 6 years of age. Because older children or adults may still be infected with whooping cough despite reduced immunity, vaccination should be conducted every 10 years after the age of 7. The pertussis vaccine is contraindicated in patients with a history of trauma at birth, a history of allergies, a family history of mental and neurological diseases, a history of convulsions, progressive neurological diseases, or acute infections. Generally, there will be pain at the local injection site, mild or moderate fever and other symptoms after vaccination. In rare cases, brain symptoms such as convulsions may occur a few days to weeks after vaccination. In recent years, new pertussis vaccines have been developed both at home and abroad. It has been reported that the cell-free vaccine contains single or all antigen components of lymphocytosis-promoting factor (LPF) and filamentous hemagglutinin (FHA), and its efficacy seems to be equivalent to that of DTP preparations. Field trials have been carried out in Japan and Switzerland, and it is believed that the vaccine is safe and effective, but it needs to be confirmed by in-depth series of studies. In addition, Italy has developed a new DNA recombinant pertussis vaccine, which is currently undergoing Phase II trials and is believed to provide a safe and effective vaccine for pertussis. my country has conducted systematic trials on acellular pertussis vaccine since 1985 and has obtained effective pertussis vaccine preparations.

4. Drug prevention: For infants and weak children who have not been vaccinated but have close contact with pertussis patients, 2.5 ml of pertussis immunoglobulin can be injected intramuscularly, or 10-20 ml of convalescent serum can be injected intramuscularly. Repeat the injection once every 5-7 days for 3 times in a row to temporarily prevent them from getting sick. It has been recently confirmed that erythromycin can reduce the infection rate of pertussis in people who have been in contact with pertussis. The dosage is 30-50 mg/kg body weight, taken orally in 4 divided doses for 5-7 days, which helps control the spread of pertussis. Some people also choose to use compound sulfamethoxazole. Infants under six months old can use 5ml of this drug emulsion (containing TMP40mg, SMZ200mg), twice a day, for 7 to 10 consecutive days.

If you have a spasmodic cough, in addition to actively treating it, it is also very important to adjust your lifestyle and make your living habits healthier. The occurrence of disease is directly related to your low resistance. Therefore, in order to prevent spasmodic cough, it is important to enhance resistance.